Pheon Therapeutics

Description: Pheon Therapeutics develops next-gen antibody-drug conjugates (ADCs) to treat resistant solid & liquid tumors, targeting hard-to-treat cancers.

Country: UK

Based in: London

Founded: 2022

Funding Stage: Pre-Seed

Tags: ['Biotechnology', 'Antibody-Drug', 'Antibodies']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.